Concordia Healthcare Corp. T.CXR.R

Veritas Research Report

[HappyRoger]

I am reading a research report by Veritas on CXR by the only analyst who was recommending to sell Valeant a year ago. This guy knows a thing or two about Valeant and pharma and from what I am reading he sees some of the same issues, only worse, with CXR. He has $27 price target on CXR.

Has anyone else read this? I am not an analyst and typically just use price to earnings, so am not too familiar with discounted cash flows he uses. I am hoping that maybe his numbers are off, but I think he has more experience than other analysts. The fact he saw the Valeant fiasco coming a year before anyone else, even the shorts, makes me think he might be onto something.

I like this company and stock, but I have to say, this report is making me very nervous going into earnings.

Roger

[Kisu]

Who was the analyst?  Link plse or copy and paste.

[HappyRoger]

I have a paper copy, not sure if it is freely available online, I will see what I can find. The analyst is Dimitry Khmelnitsky. I googled him and see he was the only one with a sell on Valeant. Here is an article on him: https://www.theglobeandmail.com/globe-investor/investment-ideas/the-lone-analyst-who-said-sell-valeant-when-hedge-funds-piled-in/article28995601/ Not sure how to make that

[fdfd12]

https://www.bnn.ca/Video/player.aspx?vid=831417 here he is on VRX  last Friday

[visionaryfool]

My fav quote from that video: "Stock could go up, could go down"

[dudsywow]

Yeah right, they mailed you a copy.... Stooge